Leukopenia and thrombocytopenia induced by etanercept: Two case reports and literature review

Revista Brasileira de Reumatologia

Volumn 52, Issue 1, 2012, Pages 107-112

  Azevedo, Valderílio Feijó ^a,b,c   Silva, Marília Barreto Gameiro ^d   Marinello, Débora Karine ^b   dos Santos, Felipe Dunin ^b   Silva, Guilherme Barreto Gameiro ^b  

^a Brazilian Society of Rheumatology BSR   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^d Faculdade Evangelica de Medicina do Parana   (Brazil)

Author keywords

Biological products; Biological therapy; Leukopenia; Neutropenia; Thrombocytopenia

Indexed keywords

ETANERCEPT; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

CASE REPORT; DRUG WITHDRAWAL; HUMAN; LEUKOPENIA; REVIEW; THROMBOCYTOPENIA; ADULT; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; MIDDLE AGED;

ADULT; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; IMMUNOGLOBULIN G; LEUKOPENIA; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; THROMBOCYTOPENIA;

EID: 84856666674     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Khanna D, McMahon M, Furst DE. Safety of tumor necrosis factoralpha antagonists Drug Saf 2004; 27(5):307-24.
2. Lahbabi I, Adamski H, Le Jean S, Cannieux V, Polard E, Chevrant- Breton J. Neutropénie et trombocitopénie chez un malade traité par etanercept pour un psoriasis. Ann Dermatol Venereol 2008; 135(5):409-10.
3. Hyrich KL, Silman AJ, Watson KD, Symmons DP. Anti-tumor necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 2004; 63(12):1538-43.
4. Malgarini RB, Pimpinella G. Etanercept and methotrexate in rheumatoid arthritis. Lancet 2004; 363(9422):1733.
5. Bruserud O, Bergheim J, Shammas FV, Nesthus I. Serum concentrations of tumour necrosis factor-alpha during chemotherapyinduced leukopenia in patients with acute leukaemia and bacterial infections. Leuk Res 1994; 18(6):415-21.
6. Vidal F, Fontova R, Richart C. Severe neutropenia and thrombocytopenia associated with infliximab. Ann Intern Med 2003; 139(3):W-W63.
7. Yazdani R, Simpson H, Kaushik VV. Incidence of cytopaenias with anti-TNF therapy. Rheumatology 2007; 46(Suppl. 1):i33.
8. Wenham C, Gadsby K, Deighton C. Three significant cases of neutropenia with etanercept. Rheumatology (Oxford) 2008; 47(3):376-7.
9. Rajakulendran S, Gadsby K, Allen D, O'Reilly S, Deighton C. Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis. Ann Rheum Dis 2006; 65(12):1678-9.
10. Montané E, Sallés M, Barriocanal A, Riera E, Costa J, Tena X. Antitumor necrosis factor-induced neutropenia: a case report with double positive rechallenges. Clin Rheumatol 2007; 26(9):1527-9.
11. Kuruvilla J, Leitch HA, Vickars LM, Galbraith PF, Li CH, Al-Saab S et al. Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor. Eur J Haematol 2003; 71(5):396-8.
12. Bértolo MB, Brenol CV, Schainberg CG, Neubarth F, Lima FAC, Laurindo IM et al. Atualização do consenso brasileiro no diagnóstico e tratamento da artrite reumatoide. Rev Bras Reumatol 2007; 47(3):151-9.